NCT05950022

Brief Summary

The purpose of the study is to assess Oxford Hip Score at baseline, at 2 months and at over 12 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
108

participants targeted

Target at P50-P75 for not_applicable

Timeline
31mo left

Started Dec 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Dec 2023Dec 2028

First Submitted

Initial submission to the registry

July 4, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

July 18, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

December 19, 2023

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

5 years

First QC Date

July 4, 2023

Last Update Submit

March 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Oxford Hip Score

    Compare the clinical improvement experienced by patients having an endoscopic tenotomy of the iliopsoas tendon at the level of the lesser trochanter versus at the level of the notch at more than 1 year minimum. The Oxford Hip Score is a self-administered patient-administered 12-item "Patient Reported Outcome Measures" questionnaire that allows the surgeon to assess clinical outcomes after total hip replacement.

    1 year

Study Arms (2)

Endoscopic tenotomy at the level of the lesser trochanter

EXPERIMENTAL

Patients will benefit from endoscopic tenotomy surgery of the iliopsoas tendon at the level of the lesser trochanter.

Procedure: Endoscopic tenotomy surgery of the iliopsoas tendon

Endoscopic tenotomy at the level of the acetabular notch

EXPERIMENTAL

Patients will benefit from endoscopic tenotomy surgery of the iliopsoas tendon at the level of the acetabular notch.

Procedure: Endoscopic tenotomy surgery of the iliopsoas tendon

Interventions

The surgery will be performed under general anesthesia with standardized multimodal analgesia. Whatever the techniques, the approaches, the instruments to perform the procedure and the postoperative course will be identical, as in usual practice.

Endoscopic tenotomy at the level of the acetabular notchEndoscopic tenotomy at the level of the lesser trochanter

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years old;
  • Definite diagnosis of iliopsoas tendinopathy due to conflict between the tendon and the prosthetic cup;
  • Failure of first-line conservative treatment;
  • Planned endoscopic tenotomy;
  • Affiliation to the social security scheme;
  • Signed informed consent.

You may not qualify if:

  • Revision total hip prosthesis, multiple operations prior to tenotomy;
  • Other surgical or medical interventions planned during the study;
  • Pregnant or likely to be pregnant (of childbearing age, without effective contraception) or breastfeeding;
  • Patient deprived of liberty or under guardianship or curatorship or unable to give consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique de la Sauvegarde

Lyon, 69009, France

RECRUITING

MeSH Terms

Conditions

Tendinopathy

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and Injuries

Central Study Contacts

Nicolas BONIN, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The patient does not know which technique he will benefit from, the surgeon will proceed with the surgery and will therefore be informed of the result of the randomization
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Interventional, comparative, randomized study, in 2 parallel groups, single-blind
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2023

First Posted

July 18, 2023

Study Start

December 19, 2023

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

April 1, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations